VitalSigns
Return to the Blog Homepage

Tag Archives: crises

June 6, 2016

0 Comments

Written by

Categories: The Week That Was

Tags: , ,

The Week That Was: Crises in Communications

No one pulled punches last week. Between Presidential candidates smearing each other in what seemed to be more roasts than policy speeches, the news was not lacking interest! So, it may have been easy to miss some healthcare highlights beneath...

The Week That Was: Crises in Healthcare Communications

“HULK-A-MANIA IS RUNNING WILD, BROTHER” Yes, we never thought we’d introduce a report with that blast-from-the-past phrase, but, there is a first for everything people. Media, business and the legal observers all turned their attention to none other than Hulk...

The Week That Was: Crises in Healthcare Communications

A STEP BACK FOR HUMANITY… AND ARTIFICIAL INTELLIGENCE Riddle me this readers, if you were an executive developer at Microsoft with too much time on your hands, what would you choose to do? The answer is clear: develop an artificial...

The Week That Was: Crises in Healthcare Communications

THE BART TWITTER HANDLE IS #FLAWSOME As fellow straphangers, we appreciate the plight of frustrated San Franciscans as they awaited delayed trains last Tuesday when the Bay Area Rapid Transit (BART) system, was if fact, not very rapid at all....

The Week That Was: Crises in Healthcare Communications

GOGO NOW A “NO-GO” AT AMERICAN AIRLINES Wifi is the most sought after feature on a flight, which is why American Airlines is seeking to end its contract with wireless Internet provider Gogo. The airline filed a lawsuit with the...

February 2, 2016

0 Comments

Written by

Categories: The Week That Was

Tags: ,

The Week That Was: Crises in Healthcare Communications

COMPOUNDING PHARMA THE MOST TRUSTED VOICE IN HEALTH? “When pigs fly.” That would’ve been our response if you had asked us a year ago the likelihood that a compounding pharmacy would be among the most trusted voices in healthcare. But,...

The Week That Was: Crises in Healthcare Communications

Are Drug Companies Getting More for the Money? Are drug companies getting more for the money they contribute to patient advocacy groups? Yes, they’re buying silence in the debate on high drug pricing, according to the former Chief of Biotechnics...